We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory panel will review Edwards Life Sciences’ PMA for its Sapien transcatheter heart valve for treatment of inoperable patients with severe aortic stenosis.